Verified· 2 sources

Vaximm AG

Summary

About the company

The core activity of VAXIMM is the development of oral T-cell immunotherapies for cancer patients.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

✓ Offered2

Oral T-cell immunotherapies

Oral T-cell immunotherapies against cancer, based on a genetically modified vector platform to activate specific, systemic T-cell responses.

Oncological development programmes

Development programmes for oncological indications, including VXM01 against glioblastoma and pancreatic cancer, as well as combinations with immunotherapies.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Vaximm AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

Vaximm AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

Vaximm AG in comparison

Industry comparisons are coming soon

Similar companies